When Lin Chen stepped into the executive floor for the first time, he felt underdressed and overexposed.
CEO Liang was not what he expected — no tie, just a white shirt, sleeves rolled up, and a pair of steel-cold eyes.
"You posted that video transcript anonymously," he said.
Lin Chen didn't flinch. "Yes."
"You know you broke protocol."
"I know I saved your company from a scandal."
Liang's lips twitched. "You've got balls, intern."
He stood, walked to the window, and continued:
"The board wants to investigate the CX-7B trial. I want answers from someone who's not already compromised."
He turned.
"You're being promoted. Temporary Medical Consultant. Access level upgraded."
Lin Chen blinked. "I thought you were going to fire me."
"I still might," Liang said, "if you screw this up."
Downstairs, Su Wanwan slammed the report on her desk.
"I'm sorry, he's what?"
"Your new team member," HR replied, unbothered. "CEO's orders."
She rubbed her temples. "Great. The clown's now a co-pilot."
An hour later, the newly formed "Joint Internal Audit Group" held its first meeting.
Ten people. One long table.
At one end: Su Wanwan.
At the other: Lin Chen, casually flipping his pen.
She frowned. "You're late."
"I'm not," he smiled. "You're early."
By mid-afternoon, Lin Chen found something odd.
One document, buried deep in the drug approval folder, wasn't labeled properly.
It was an off-contract research collaboration letter — signed by a third-party pharmaceutical group: Haoyuan Biotech.
Worse: it wasn't approved by the ethics committee.
[System prompt: Hidden conflict of interest detected. Estimated source: executive-level channel.]
Lin Chen leaned back in his chair.
"Looks like someone high up was playing doctor."
But before he could say more, Su Wanwan received a message on her phone.
Her face froze.
"…The legal rep from Haoyuan is coming tomorrow."
She turned the screen toward him.
Lin Chen narrowed his eyes.
The photo showed a middle-aged man in a sharp gray suit.
Su Wanwan said quietly:
"…He's my father."
林尘第一次踏入公司高层办公区,感觉自己穿得不够正式,气场不够厚重.
CEO梁远川,和他想象中不一样——
没有领带,只穿着白衬衫,袖子挽起,眼神像刀.
"那份视频节录,是你匿名发的?"
林尘毫不回避:"是."
"你违反了公司条例."
"但我救了你们公司免于一场丑闻."
梁远川嘴角轻挑:"胆子不小,小子."
他走到窗前,背对阳光,说:
"董事会决定立案调查CX-7B临床试验.我需要一个未被污染的人来找真相."
他转身.
"从今天起,你被'临时提拔'为医学顾问.权限等级提升."
林尘眨了眨眼:"我还以为你会开除我."
"办砸了,我还是会的."梁远川淡淡道.
另一边,苏婉婉几乎要把报告拍穿.
"对不起,你说什么?"
"林尘,现在是你团队成员."人事部面不改色.
她捂着太阳穴:"...小丑现在上台当主角了."
一小时后,"联合内部调查组"第一次会议召开.
十人一桌,
一头是冷艳严肃的苏婉婉,
一头是笑容轻浮的林尘,转着圆珠笔.
"你迟到了."她冷声.
"你早到了."他笑.
下午三点,林尘在审阅药品资料时,发现一个"标签错误"的文档.
打开一看——
是一份未备案的外部合作协议,签署方竟是"浩源生物科技".
更诡异的是:该协议从未通过伦理委员会审批.
[系统提示:检测到潜在利益冲突,源头疑似高管渠道.]
林尘靠在椅背上:
"原来有人在背地里'兼任'医生?"
他正准备继续查线索,苏婉婉手机震动.
她一看,脸色骤变.
"...浩源那边的代表,明天来访."
她把手机转给他看.
林尘眯起眼.
照片中,是一名身穿灰西装的中年男子.
苏婉婉缓缓说出一句话:
"...他是我父亲."